Announce Date | 02/18/2025 |
EPS Normalized Actual | $-0.13 (Miss by $-0.12) |
EPS GAAP Actual | $-0.13 (Miss by $-0.12) |
Revenue Actual | $1.947B |
Revenue Surprise | Beat by $1947M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.6785 |
EPS GAAP Estimate | $0.6785 |
Revenue Estimate | $1.888353011B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.05 | 15.3 | 0.8442 | 1.30015 | 1 |
Dec 2028 | 1.1 | 14.6 | 0.96661 | 1.25454 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 1.947B | -13.1% | 1947M |
FQ3 2024 (Sep 2024) | -1.23 | -1.23 | 1.833B | -37.59% | 1833M |
FQ2 2024 (Jun 2024) | 0.21 | 0.21 | 1.967B | -13.68% | 1967M |
FQ1 2024 (Mar 2024) | 0.82 | 0.82 | 1.863B | -22.71% | 1863M |
FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 2.202B | -21.71% | 2202M |
FQ3 2023 (Sep 2023) | 3.51 | 3.51 | 2.522B | -7.02% | 2522M |
FQ2 2023 (Jun 2023) | 1.29 | 1.29 | 2.236B | -40.61% | 2236M |
FQ1 2023 (Mar 2023) | 1.94 | 1.94 | 2.286B | 100% | 2286M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.6785
Consensus Revenue Estimates
1.888353011B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.19124 | -- | 0.12945 | 0.31191 | 1 |
FQ2 2027 (Jun 2027) | 0.18457 | -- | 0.12494 | 0.30103 | 1 |
FQ1 2027 (Mar 2027) | 0.18913 | -- | 0.12802 | 0.30847 | 1 |
FQ4 2026 (Oct 2026) | 0.65583 | -- | 0.56975 | 0.74314 | 1 |
FQ3 2026 (Jul 2026) | 0.68034 | -- | 0.59105 | 0.77091 | 1 |
FQ2 2026 (Jun 2026) | 0.76291 | -- | 0.67977 | 0.87137 | 1 |
FQ1 2026 (Mar 2026) | 0.30308 | -- | 0.30308 | 0.30308 | 1 |
FQ4 2025 (Oct 2025) | 0.71164 | 60.65 | 0.61824 | 0.80638 | 2 |
FQ3 2025 (Jul 2025) | 0.79568 | 254.58 | 0.69125 | 0.90161 | 2 |
FQ2 2025 (Jun 2025) | 0.6785 | 69.05 | 0.61478 | 0.76133 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.87B | -- | 1.41B | 2.78B | 2 |
FQ2 2027 (Jun 2027) | 1.85B | -- | 1.39B | 2.75B | 2 |
FQ1 2027 (Mar 2027) | 1.84B | -- | 1.38B | 2.73B | 2 |
FQ4 2026 (Oct 2026) | 1.94B | -- | 1.74B | 2.14B | 1 |
FQ3 2026 (Jul 2026) | 1.93B | -- | 1.74B | 2.13B | 1 |
FQ2 2026 (Jun 2026) | 1.93B | -- | 1.77B | 2.14B | 1 |
FQ1 2026 (Mar 2026) | 1.9B | -- | 1.9B | 1.9B | 1 |
FQ4 2025 (Oct 2025) | 1.89B | -2.87 | 1.7B | 2.09B | 0 |
FQ3 2025 (Jul 2025) | 1.9B | 3.59 | 1.71B | 2.1B | 0 |
FQ2 2025 (Jun 2025) | 1.89B | -4.16 | 1.75B | 2.07B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 100% | |
FQ3 2024 (Sep 2024) | -1.23 | -1.23 | 100% | |
FQ2 2024 (Jun 2024) | 0.21 | 0.21 | 100% | |
FQ1 2024 (Mar 2024) | 0.82 | 0.82 | 100% | |
FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 100% | |
FQ3 2023 (Sep 2023) | 3.51 | 3.51 | 100% | |
FQ2 2023 (Jun 2023) | 1.29 | 1.29 | 100% | |
FQ1 2023 (Mar 2023) | 1.94 | 1.94 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1.95B | $1947M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.83B | $1833M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.97B | $1967M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.86B | $1863M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.2B | $2202M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.52B | $2522M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.24B | $2236M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2.29B | $2286M | 100% |